Conference Schedule
22th, November, 2019 (Friday) |
|||
Report Hall, 3rd Floor |
|||
08:00-08:30 |
Opening Ceremony |
||
08:30-10:10 |
Session I Stem Cell Niche |
||
Chairs |
Dai, Jianwu / Pei, Renjun |
||
08:30-08:50 |
解亭 |
美国斯托尔斯医学研究所 |
Adult stem cell development: tales of two niches |
08:50-09:10 |
袭荣文 |
北京生命科学研究所 |
Stem cells and epithelial homeostasis in fly midgut |
09:10-09:30 |
莫玮 |
厦门大学生命科学学院 |
Stem cell death in gut promotes bowel inflammation |
09:30-09:50 |
陈婷 |
北京生命科学研究所 |
Skin regional differences |
09:50-10:10 |
许韧 |
厦门大学医学院 School of Medicine, Xiamen University |
Building bone by targeting skeletal endothelium |
10:10-10:30 |
Coffee Break |
||
10:30-12:00 |
Session II Stem Cells and Tissue Engineering |
||
Chairs |
Liu, Gang / Xi, Rongwen |
||
10:30-10:50 |
胡宝洋 |
中国科学院动物研究所 |
Neural differentiation for discovery and therapy |
10:50-11:10 |
戴建武 |
中国科学院遗传与发育生物学研究所 |
Collagen scaffolds with stem cells for spinal cord injury repair: from animal models to clinical study |
11:10-11:30 |
裴仁军 |
中国科学院苏州纳米技术与纳米仿生研究所 |
Stem cells-encapsulating injectable hydrogels for tissue regeneration |
11:30-11:50 |
金子兵 |
温州医科大学 |
Conversion of functional ocular cells from fibroblasts by small molecule cocktails |
11:50-12:00 |
张小薇 |
厦门大学药学院 |
Diet-induced obesity drives a loss of antimicrobial defense function of dermal adipocyte progenitors |
12:00-14:00 |
Lunch and Coffee Break |
|
|
14:00-15:40 |
Session III Neural Stem Cells |
||
Chairs |
Hu, Baoyang / Xu, Haiwei |
||
14:00-14:20 |
沈沁 |
同济大学 |
Development and maintenance of neural stem cells |
14:20-14:40 |
Ong, Sek Tong (Derrick) |
新加坡国立大学 |
Diving into glioblastoma epigenetics |
14:40-15:00 |
向孟清 |
中山大学 |
Transcriptional regulation of retinal development and neural reprogramming |
15:00-15:20 |
张亮 |
厦门大学生命科学学院 |
Nucleoporin Seh1 interacts with Olig2/Brd7 to promote oligodendrocyte differentiation and myelination |
15:20-15:40 |
邵志成 Shao, Zhicheng |
厦门大学医学院 |
iPSC-derived cortical interneurons as developmental model of schizophrenia |
15:40-16:00 |
Coffee Break |
||
16:00-17:40 |
Session IV Stem Cells in Retinal Degeneration and Regeneration |
||
Chairs |
Xie, Ting / Jin, Zibing |
||
16:00-16:20 |
彭智培 |
香港中文大学 |
micro-RNA and Neural Differentiation of Human Adult Stem Cells |
16:20-16:40 |
徐国彤 |
同济大学 |
The combination of bFGF and CHIR99021 maintains stable self-renewal of mouse adult retinal progenitor cells |
16:40-17:00 |
徐海伟 |
陆军军医大学 |
Intercellular communications and materials transfer between grafted stem cells and degenerative retina cells and the cell fate commitment |
17:00-17:20 |
王丽强 |
中国人民解放军总医院 Chinese PLA General Hospital |
The function and regulation mechanisms of Sox9+ cells in the repair of liver, kidney and eye damage |
17:20-17:40 |
陈舒怡 |
中山大学 |
Retinal regeneration: can we count on glia? |
17:40 |
Dinner |
||
Report Hall, 3rd Floor |
|||
08:30-10:30 |
Session I Stem Cell Maintenance and Differentiation |
||
Chairs |
Jin, Yan / Shen, Qin |
||
08:30-08:50 |
袁宝珠 |
中国食品药品检定研究院 National Institutes for Food and Drug Control |
The study of stem cell quality and its quality control |
08:50-09:10 |
阴正勤 |
陆军军医大学 |
The effect of exogenous stem cells on Müller cell reprogramming during retinal degeneration and its mechanisms |
09:10-09:30 |
刘祖国 |
厦门大学医学院 |
Challenges and solutions of limbal stem cell transplantation |
09:30-09:50 |
陈建苏 |
暨南大学 Jinan University |
Human iPSC derived disease model of USH2A-associated retinitis pigmentosa and the retinal organoid in early stage |
09:50-10:10 |
钟秀风 |
中山大学 |
Regulation of photoreceptor cell specification and maturation with hiPSCs for retinal degenerations |
10:10-10:30 |
张潮 |
美国康奈尔大学医学院 |
Lipid deprivation induces a stable intermediate, naïve-to-primed state of pluripotency in human PSC |
10:30-10:50 |
Coffee Break |
||
10:50-11:50 |
Session II Mesenchymal Stem Cells and Hematopoietic Stem Cells |
||
Chairs |
Yuan, Baozhu / Zhang, Hong |
||
10:50-11:10 |
金岩 |
空军军医大学 |
The functional maintenance of MSC and impact factors |
11:10-11:30 |
程临钊 |
中国科学技术大学 University of Science and Technology of China |
Human stem cell derived RBCs and exosomes |
11:30-11:50 |
郑俊克 |
上海交通大学医学院 Shanghai Jiao Tong University School of Medicine |
Metabolic regulation of leukemia stem cells |
11:50-12:00 |
谢晶 Xie, Jing |
陆军军医大学 Army Medical University |
Olfactory ensheathing cells grafted into the retina of RCS rats suppress inflammation and gliosis and the related mechanisms |
12:00-14:00 |
Lunch and Coffee Break |
||
Session III Genetics and Epigenetics of Stem Cells |
|||
Chairs |
Cheng, Linzhao / Zheng, Junke |
||
14:00-14:20 |
薛天 |
中国科学技术大学 University of Science and Technology of China |
Chromatin accessibility analysis reveals regulatory dynamics of developing human retina and hiPSC-derived retinal organoid |
14:20-14:40 |
胡德庆 |
天津医科大学 |
Function and molecular mechanisms of MLL (mixed lineage leukemia) complexes in H3K4 methylation and early embryonic development |
14:40-15:00 |
费继锋 |
华南师范大学 |
Developing molecular genetics in the axolotl (Ambystoma mexicanum) and their applications in studying organ regeneration |
15:00-15:20 |
徐秀琴 |
厦门大学医学院干细胞研究所 |
Alternative splicing in the regulation of embryonic stem cell differentiation |
15:20-15:30 |
刘洪军 |
上海科技大学 |
Regeneration of functional retinal ganglion cells by reprogramming retinal interneurons in vivo |
15:30-15:50 |
Coffee Break |
||
15:50-17:30 |
Session IV Stem Cell Tracking and Chasing |
||
Chairs |
Liu,Zuguo / Xue, Tian |
||
15:50-16:10 |
徐庆国 |
美国弗吉尼亚联邦大学药学院 |
New method to treat corneal graft rejection |
16:10-16:30 |
张宏 |
浙江大学医学院附属第二医院 The Second Affiliated Hospital Zhejiang University School of Medicine |
Stem cell molecular imaging |
16:30-16:50 |
顾宁 |
东南大学 |
Labeling of stem cells with magnetic nanomaterials |
16:50-17:10 |
何耀 |
苏州大学功能纳米与软物质研究院 |
Silicon-based nanoprobes for biosensing and bioimaging analysis |
17:10-17:30 |
刘刚 |
厦门大学分子影像暨转化医学研究中心 |
Cellular membrane-derived nanovesicles as a versatile drug delivery system for cancer theranostics |
17:30 |
Dinner |
||
Report Hall, 3rd Floor |
|||
08:30-10:10 |
Session I Ocular Surface Stem Cells |
||
Chairs |
Pang,Chi-Pui / Li, Wei |
||
08:30-08:50 |
Jester, James V. |
加利福尼亚大学欧文分校 University of California Irvine, Irvine, CA, United States |
Mechanisms of meibocyte renewal and differentiation in the meibomian gland |
08:50-09:10 |
Makarenkova, Helen P. |
美国斯克里普斯研究所细胞与分子生物学系 |
Unravelling the mystery of stem/progenitor cells hierarchy in mouse lacrimal gland |
09:10-09:30 |
Hirayama, Masatoshi |
日本庆应义塾大学医学部 Keio University School of Medicine, Tokyo, Japan |
Recent advances in functional lacrimal gland regeneration |
09:30-09:50 |
李贵刚 |
华中科技大学 |
The possibility for transforming mature cornea epithelial cells into their stem cells |
09:50-10:10 |
马永慧 |
厦门大学医学院生命伦理中心 Centre for Bioethics, School of Medicine, Xiamen University |
Stem cell research and clinical applications: ethics and governance issues |
10:10-10:30 |
Coffee Break |
||
10:30-12:10 |
Session II Stem Cell Based Therapy |
||
Chairs |
James V. Jester / Helen P. Makarenkova |
||
10:30-10:50 |
周庆军 |
山东省眼科研究所 Shandong Eye Institute, Shandong Academy of Medical Sciences |
Corneal stem cells: from bench to bedside |
10:50-11:10 |
李炜 |
厦门大学医学院 |
Dynamic gene profile and phenotypic transition from human embryonic stem cells to corneal epithelial cells |
11:10-11:30 |
李世迎 |
陆军军医大学 |
Choice is important: 3.5 years follow-up of open label phase 1 study of human embryonic stem cell-derived retinal pigment epithelial cells in early stage macular degeneration |
11:30-11:50 |
谢华桃 |
华中科技大学 |
Stem cells in ocular surface----research progress and clinical application |
11:50-12:10 |
王晓昱 |
厦门国际信托有限公司 Xiamen International Trust Co., Ltd |
How the PE capital company evaluate stem cell research achievements in China |
12:10 |
Closing Remarks |
||
Speakers Introduction
陈婷
Chen, Ting
Institute: National Institute of Biological Sciences，Beijing
Email address: chenting@nibs.ac.cn
Dr. Ting Chen obtained her PhD in Dr. Ian Macara's lab at the University of Virginia studying Cell and Developmental Biology. Then from 2007-2012, she joined Dr. Elaine Fuchs' lab at the Rockefeller University for postdoc training. During that time her work focused on the mechanistic study of skin stem cell long-term self-renewal ability. In 2013, Dr. Chen established her own research lab at the National Institute of Biological Sciences in Beijing China. Her lab is interested in the areas of stem cell and niche crosstalk, developing novel in vivo gene editing methods, and the skin regional differences regarding both tissue regeneration pattern and disease hotspots. Dr. Chen has received multiple recognitions, including: Empire State Stem Cell Scholars: Fellow-to-Faculty Awards in Stem Cell Research, American Society of Cell Biology Merton Bernfield Memorial Award, and the China 1000 Young Talents Award etc.
陈舒怡
Chen, Shuyi
Institute: Sun Yat-sen University
Email address: chenshy23@mail.sysu.edu.cn
Dr. Shuyi Chen is currently an investigator at the State Key Laboratory of Ophthalmology at Zhongshan Ophthalmic Center. Dr. Chen holds a bachelor degree in Medicine from Norman Bethune Medical University, and a Ph.D. from the Department of Anatomy and Cell Biology of Kansas University, Medical Center. During her graduate study, Dr. Chen used fruit fly to study the regulatory relationship between adult stem cells and their niches. After graduate study, Dr. Chen conducted her postdoctoral training in the Stowers Institute for Medical Research, focusing on retinal development. Now at ZOC, Dr. Chen’s lab is devoted to study the mechanisms of retinal development and retinal regeneration. Dr. Chen’s lab uses model animals and cultured cells as objects and combines classical genetics, molecular biology and developmental biology with advanced biological techniques, such as high throughput genomics and genome editing, to explore the molecular and cellular mechanisms governing these processes. Dr. Chen’s studies have been published in renowned journals in the field such as PNAS, Cell Research, and IOVS.
陈建苏
Chen, Jiansu
Institute: Jinan University
Email address: chenjiansu2000@163.com
As a professor and doctoral supervisor, Prof. Chen has been engaged in the research on eye stem cells and eye regenerative medicine for a long time. At present, she is especially interested in the study on ocular precise regenerative medicine, such as retinal organoid disease models derived from induced pluripotent stem cells (iPSCs) of patients to probe target-based ocular pathogenesis and intervention strategy. She is also working in ocular tissue engineering and bio-printing research. As a PI, she has presided over 4 items of National Natural Scientific Fund of China and 2 items of Special Funds for major science and technology projects of Guangdong Province. She has published more than 140 research papers and more than 40 SCI papers.
程临钊
Cheng, Linzhao
Institute: University of Science and Technology of China
Email address: lzcheng@yahoo.com
Linzhao Cheng is an internationally renowned stem cell researcher and expert on human genome editing. Since April 2019, Dr. Cheng is a chair professor and the founding Director for the Division of Life Sciences and Medicine in the University of Sciences and Technology of China (USTC). He has been a tenured Professor of Medicine and Oncology in Johns Hopkins University School of Medicine (JHUSOM). He was the Lucas Lynn endowed chair of Hematology and Associate Director for Research in Division of Hematology in JHUSOM. After receiving his PhD degree in Molecular Biology and Genetics from JHUSOM in 1991, Dr. Cheng has been working on stem cell research in NIH, two biotech companies and JHUSOM (since 1999). He was a recipient of USA Presidential Early Career Award for Scientists and Engineers (PECASE, 2003). In 2012, Dr. Cheng was elected as a Fellow of the American Association for the Advancement of Sciences (AAAS) and an endowed chair in JHUSOM. His current research is focusing on using human stem cells for human biology and engineering including cell and gene therapies, especially for the blood and vascular systems. He has published more than 110 peer-reviewed papers which were cited for more than 1600 times. His current H-index is 61.
戴建武
Dai, Jianwu
Institute: Genetics and Developmental Biology, Chinese Academy of Science
Email address: jwdai@genetics.ac.cn
Dr. Dai has completed his PhD from Duke University and postdoctoral studies from Harvard Medical School. He is now the Director of the Center for Regenerative Medicine, Institute of Genetics and Developmental Biology at Chinese Academy of Sciences. He has developed functional collagen scaffolds with growth factors and stem cell binding abilities which could actively induce a variety of tissue regeneration. He has published over 200 papers in reputed journals in the field of regenerative medicine and has been serving as an editorial board member of Biomaterials. He has pioneered several tissue regenerative clinical studies including spinal cord injury repair.
费继锋
Fei, Jifeng
Institute: South China Normal University
Email address: jifengfei@m.scnu.edu.cn
As a distinguished Professor of the Pearl River Scholar in Guangdong Provinc,he is using diverse model organisms, including mice and salamanders, to study the mechanisms of the central nervous system (CNS) development and regeneration. In these years, Professor Fei is focusing on, particularly using the axolotl (Ambystoma mexicanum), a type of salamanders, to study the spinal cord regeneration. He has established the live-imaging system to visualize the process of the spinal cord regeneration, and preliminarily identified the key genes involved in spinal cord regeneration. In addition, he has developed a series of CRISPR/Cas9 based molecular genetic tools in axolotl and decoded the axolotl genome that is the largest genome assembled so far. His study may provide the new theories to improve the limited mammalian tissue regeneration. As first (co-first) and corresponding (co-corresponding) author, he has published research work on a series of peer-reviewed journals, such as Nature, Nature Protocols, PLOS Biology, PNAS, Cell Reports, Stem Cell Reports.
顾宁
Gu, Ning
Institute: Southeast University
Email address: guning@seu.edu.cn
Dr. Ning Gu is a Professor in Biological Science and Medical Engineering at Southeast University, Nanjing, China. He is currently director of Jiangsu Key Laboratory for Biomaterials and Devices, and chief researcher of Suzhou Collaborative Innovation Center of Nano-science and Technology. His professional positions also include: member of the Technical Experts of the National Nanotechnology Coordination Steering Committee; deputy leader of the National Key R&D Project “Biomedical materials R&D and Tissue Organ Repair and Replacement”; member of the General Group of Nanotechnology; Committee member of Department of Biology and Medicine under Science and Technology Commission, Ministry of Education.
Dr. Gu dedicates himself to the development of nanotechnology, of special interests are in the fields of macro preparation, characterization and standard, biological effect and biomedical application of “pharmaceutical ferro-based nano-materials”. He is the author of over 90 patent applications and over 500 scientific papers on peer-reviewed journals including Nat Mat, Adv Mat, Biomaterials, ACS Nano, Cell Res, JCR etc. His work on preparation of nano-ferric oxide was approved as the standard substance of national relaxation rate, and the development of Oligosaccharides ultra-paramagnetic iron oxide APIs and injection was the earliest approved into clinical trials of inorganic nano-drugs in China.
Hirayama, Masatoshi
Institute: Keio University School of Medicine, Japan
Email address: mar.hirayama@gmail.com
Assistant Professor, Department of Ophthalmology, Tokyo Dental College Ichikawa General Hospital. Lacrimal glands play an important role in protecting ocular surface epithelium via tear secretion. Lacrimal gland regeneration has been expected as a novel approach to treat the dry eye disease. He has studied about developmental mechanisms of the lacrimal glands and elucidated a possibility of the functional lacrimal gland regeneration at Keio University School of Medicine (JAPAN) and the Salk Institute for biological studies (USA).
何耀
He, Yao
Institute: Soochow University
Email address: yaohe@suda.edu.cn
Prof. He is the Principal Investigator of Institute of Functional Nano&Soft Materials at Soochow University in China. Starting from 2009 when Prof. He established his group, he has authored over 100 peer-reviewed papers, with the number of SCI citations more than 7000. Currently, he is the Associate Editor (2017-) of Frontiers in Chemistry (nanoscience section); vice-chairman of the biomedical photonics society of the Chinese society of biomedical engineering. He served as a chief scientist of the “youth 973” project (National key scientific research projects) in 2013. Prof. He received the awards including the National Science and Technology Leading Talent Award in 2012, the First prize of Jiangsu Science and Technology Award in 2017 (Ranking first).
胡德庆
Hu, Deqing
Institute: Tianjin Medical University
Email address: hudq@tmu.edu.cn
Dr. Deqing Hu is a professor in the Department of Cell Biology at Tianjin Medical University. He received his Ph.D degree at Institute of Biophysics (IBP), Chinese Academy of Sciences and finished his postdoctoral training at Stowers Institute for Medical Research and Northwestern University under the guidance of Profs. Ali Shilatifard and Linheng Li. Over the past few years, his research has been directed to understand the functional diversity and molecular basis of mammalian MLL complexes in H3K4 methylation and early embryonic development. Dr. Hu published his research findings as a first or co-senior author in prestigious journals including Molecular Cell, Nature Struct Mol Biol, Genes and Development, Mol Cell Biol, etc. Dr. Hu’s work has been well recognized by peers around the world and cited over 1300 times. Dr. Hu was awarded the First Prize of DI'AO Scholarship of Chinese Academy of Sciences and Translational Bridge Program Fellow award in Lymphoma Research of Baskes foundation in USA. The research is currently supported by National and Tian Jin Natural Science Foundation.
胡宝洋
Hu, Baoyang
Institute: Institute of Zoology, Chinese Academy of Sciences
Email address: byhu@ioz.ac.cn
Dr. Hu Baoyang is the Principal Investigator of Stem Cell Biology and Regenerative Medicine Lab at the Institute of Zoology, Chinese Academy of Sciences, and the recipient of One Hundred Talents Program award. He is currently the Executive Director of the Institute of Stem Cell and Regenerative, Chinese Academy of Science, the Executive Vice President of the Savaid Medical School of the University of Chinese Academy of Sciences and the deputy director of the State Key Laboratory of Stem Cell and Reproductive Biology.
Dr. Hu’s lab focuses on brain development and diseases, stem cell differentiation and clinical application, and has a series of important achievements in the evolutionary characteristics of brain development and regulation, the differentiation mechanism of the nervous system, and the clinical application of differentiated cells. Dr. Hu and his team discovered the heterogeneity and regularity of neural differentiated human iPS for the first time (PNAS, 2010), firstly acquired the SIRT6 knockout monkeys and revealed its regulatory and evolutionary properties (Nature, 2018), and took the head in promoting the Clinical studies of treating Parkinson's disease with hESC differentiation cells.
Jester , James V.
Institute: University of California Irvine, United States
Email address: jjester@uci.edu
Professor of Ophthalmology and Biomedical Engineering, Jack H. Skirball Endowed Research Chair. Dr. Jester is currently the Jack H. Skirball Endowed Research Chair and Professor of Ophthalmology and Biomedical Engineering at the University of California, Irvine. Dr. Jester’s trained as an Experimental Ocular Pathologist whose research has focused on the cellular and molecular biology of the cornea and ocular surface. Dr. Jester has extensive experience using multi-dimensional imaging modalities to evaluate ocular structure and function. His current research focuses on age-related meibomian gland dysfunction and understanding the cellular and molecular mechanisms controlling meibocyte progenitor cell proliferation and survival as well as meibocyte differentiation, lipid synthesis and disintegration.
金岩
Jin, Yan
Institute: Air Force Medical University
Email address: yanjin@fmmu.edu.cn
Professor, predecessor chairman of Chinese Society of Tissue Engineering and Regenerative Medicine (2015-2019) and Chairman of Chinese Society of Oral Biomedicine (2017-2020). Prof. Yan Jin established the Center for Tissue Engineering of Fourth Military Medical University in 2000, and he has been serving as the director for 20 years since then. In 2015, he was awarded as the “Top Ten Newsmakers of Science” in China. Prof. Jin has long been engaged in scientific researches on tissue engineering and regenerative medicine. Prof. Jin and his collaborators have successfully produced the tissue engineering skin, which is the first CFDA-approved tissue engineering product in China. His group is also the first in the world to develop a biotechnological product of cornea, which has been reported by Nature and recognized as the representative of life science in the “Top Five Scientific Revolutions of China” by BBC. Along with his co-workers, Prof. Yan Jin has first launched clinical trials on regeneration of dental pulp and periodontium by using mesenchymal stem cells (MSCs) in the world, and he has accomplished the intact regeneration of pulp tissue, established a revolutionary approach to dental pulp diseases. He has published over 199 papers in SCI journals, such as Sci Translation Med, Cell Metabolism, Cell Death and Differentiation, Stem Cells, and Biomaterials.
金子兵
Jin, Zibing
Institute: Wenzhou Medical University
Email address: jinzb@mail.eye.ac.cn
Dr. Jin is the professor of Wenzhou Medical University (WMU) and director of The Stem Cell Research Institute, WMU. He is heading the Laboratory for Stem Cell and Retinal Regeneration as well as the Division of Ophthalmic Genetics, The Eye Hospital of WMU. He received 3-year resident training in Ophthalmology after obtained his M.D. (MBBS) from Wenzhou Medical College in 2000. He obtained Ph.D degree from University of Miyazaki in 2007 and then worked for 2-year as a postdoctoral fellow (JSPS fellowship) and 2-year research scientist (FPR) at the RIKEN Center for Developmental Biology under Dr. Masayo Takahashi’s supervision before returning to Wenzhou Medical College (renamed as University in 2013) in 2011. He focuses on stem cell translational medicine and genetic mechanisms of ocular diseases. His lab is dedicating to make efforts on elucidating the disease mechanisms of inherited retinal degeneration and children ocular disorders, translating laboratory technology to improve bedside outcome, and solving key basic problems.
李贵刚
Li, Guigang
Institute: Huazhong University of Science and Technology
Email address: guigli@163.com
Dr. Guigang Li is professor, chief physician, master tutor, deputy Director of Ophthalmology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology. Selected as a training project for the young talents of middle-aged and young people in Wuhan in 2014. From February to April, 2009, Shandong Eye Institute, Qingdao Eye Hospital, majored in corneal disease. February 2011-February 2012, American Ocular Surface Research and Education Fund (OSREF) Visiting Scholar. November 2016 at the US LUSK Eye Center Advanced corneal endothelial transplantation. The main research direction: corneal disease and ocular surface disease, eye bank technology, accumulated more than 1000 cases of corneal transplantation, hosted two projects funded by the National Natural Science Foundation, and published more than 40 academic papers.
李世迎
Li, Shiying
Institute: Army Medical University
Email address: shiying_li@126.com
Dr. Shiying Li is the Director Assistant, Doctoral Supervisor, Associate Professor, Associate Chief Physician of the first affiliated hospital (Southwest Hospital) to Army Medical University. He was a Postdoctoral fellow at the University of Sydney, Visiting scholar of Moorfields Eye Hospital, London. He is currently in charge of the ophthalmic stem cell group 2 (vitreoretinal surgery) in southwest hospital. Also being the head of ophthalmic ward A and the group leader of clinical visual electrophysiology. He is mainly engaged in clinical and basic research on vitreoretinal diseases and visual electrophysiology, focusing on the diagnosis and treatment of various difficult ocular fundus diseases. He is now the group leader of visual physiology group of ophthalmology branch of Chinese Ophthalmological Society, the vice chairman of visual physiology group of ophthalmology branch of Chinese Medical Doctor Association, and the director of the International Society for Clinical Electrophysiology of Vision (ISCEV).
李炜
Li, Wei
Institute: School of Medicine, Xiamen University
Email address: wei1018@xmu.edu.cn
Dr. Wei Li is the professor of Ophthalmology of the Eye Institute of Xiamen University, director of the department of Ophthalmology & Visual Science, vice dean of the School of Medicine, Xiamen University. He is also Honorary Professor of School of Optometry & Vision Sciences of Cardiff University. His basic research is mainly focused on corneal limbal stem cell, corneal tissue engineering and the mechanism of dry eye. His clinical research is mainly centered on ocular surface reconstruction, as well as the treatment of severe ocular surface and corneal diseases. He has published more than 70 papers in peer-reviewed journals such as Cell Res, J Pathol, Am J Pathol, IOVS, Ocular Surface, J Bio Chem. He is now active member of Chinese Medical Association (CMA), Asia Cornea Society (ACS), Asia Dry Eye Society (ADES), Association for Research in Vision and Ophthalmology (ARVO), International Ocular Surface Society (IOSS), and American Academy of Ophthalmology (AAO). He is a committee member of Chinese Cornea Society, communication editor of Chinese Journal of Ophthalmology, academic editor of PLOS ONE and Exp Eye Res, reviewer of National Natural Science Foundation of China.
刘刚
Liu, Gang
Institute: School of Public Health, Xiamen University
Email address: gangliu.cmitm@xmu.edu.cn
Dr. Gang Liu is a Professor of Biomedical and Bioengineering at the Center for Molecular Imaging and Translational Medicine, Xiamen University. He is particularly interested in developing new molecular imaging probes through cellular/molecular-biology-oriented methods and applying novel imaging and therapeutic agents for cancer theranostics.
刘祖国
Liu, Zuguo
Institute: School of Medicine, Xiamen University
Email address: zuguoliu@xmu.edu.cn
Dr. Zuguo Liu is the professor of ophthalmology, the director of eye institute and stem cell institute of Xiamen University, and the chairman of ophthalmology and vision science key laboratory of Fujian Province. He was entitled distinguished “Changjiang” professor in 2002 by the education department of Peoples Republic of China. For the last 30 years, he has been focusing on ocular surface and cornea. He is the council member of Asia Cornea Disease Association and the president of Asia Dry Eye Society. In China, he serves as the standing committee of the Ophthalmology Branch and vice chairman of Cornea Disease Advisory Board, in both Chinese Medical Association and Chinese Physician Association. He is the deputy editor-in-chief for top journals in China, including Chinese Journal of Ophthalmology, Chinese Cell and Stem Cell Transplantation and Chinese Journal of Optometry &Ophthalmology and Visual Science. Dr. Liu’s research projects had been supported by more than 50 grants. He has published more than 400 papers. As the inventor, he was authorized 10 patents and disclosed 12 patents. He established the first ocular surface disease research center and opened the first Dry Eye Clinic in China.
Makarenkova, Helen
P.
Institute: The Scripps Research Institute, United States
Email address: hmakarenk@scripps.edu
Associate Professor at the Department of Molecular Medicine, Scripps Research, La Jolla. Helen Makarenkova’s research is focused on analysis of stem and progenitor cell function and tissue regeneration. Dr. Makarenkova completed her PhD at the St. Petersburg State University, Russia. She was awarded the Welcome Trust International Travel Fellowship in 1995 and worked at the University College London (UCL) on limbal regeneration. She moved to Skirball Institute, NYU Medical Center, New York in 1998, where she pioneered studies on lacrimal gland development and regeneration and established new strategy for successful progenitor cell transplantation into the injured and diseased lacrimal gland. Dr. Makarenkova was appointed as an Associate Fellow at the Neurosciences Institute in San Diego in 2001. She joined the Scripps Research Institute Faculty in 2008. Her more recent work centers on inflammation-induced changes in spatiotemporal properties of the stem cell niche and lacrimal gland function. She also serves as a member of Scripps Research’s Internship Programs: Summer Undergraduate Research Fellowship (SURF) and High School Student Research Education Program (HSSREP and/or LSSI). She is a member of the SoCal Stem Cell Consortium and the San Diego Skeletal Muscle Research Center (SDMRC).
马永慧
Ma, Yonghui
Institute: School of Medicine, Xiamen University
Email address: yhma@xmu.edu.cn
Yonghui Ma is now Associate Professor (since 2017) on medical ethics/bioethics and also the Associate Director of the Interdisciplinary Center for Bioethics at School of Medicine, Xiamen University. She had a bachelor degree of Medicine, and obtained her PhD on bioethics from the University of Manchester in the UK on 2013. She is also member of International Association of Bioethics (IAB), member of Chinese Bioethics Association, editorial member of Chinese Medical Ethics Journal, editorial member of Nursing Ethics (SCI), editorial member of BMC Life Science, Policy and Society, and Institutional Review Board member (IRB,or Ethics consultants) in many tertiary hospitals in Xiamen as well as some other academic Institutions. Dr. Ma’s research interests focus on genetic ethics, clinical ethics, ethics of new biomedical technology, cross-cultural bioethics, and recently she has a particular interest in ethics of human microbiome research.
莫玮
Mo, Wei
Institute: School of Life Science, Xiamen University
Email address: wmo@xmu.edu.cn
Dr. Wei Mo is now Professor in School of Life Science, Xiamen University. His lab is to investigate the role of cancer stem cells within cancers in central and peripheral neural system. He is also interested in cell fate decision of adult stem cells in multiple organs.
Ong, Sek Tong
Institute: National University of Singapore, Singapore
Email address: phsostd@nus.edu.sg
Dr. Ong obtained his Bachelor in Science (1st class Honors) and Masters in Biology at the National University of Singapore (NUS), and Ph.D. (Chemical Biology) at The Scripps Research Institute (TSRI), USA, where he trained under Prof. Jeffery Kelly, a pioneer in the field of proteostasis. Next, he was mentored by Prof. Ronald DePinho, a world expert in aging and cancer, first at Dana Farber Cancer Institute/ Harvard Medical School, and then at the University of Texas MD Anderson Cancer Center (UT MDACC), USA, for his postdoctoral training. He joined the Department of Physiology at NUS as the President’s Assistant Professor in 2017. His research interests lie in the area of brain stem cell biology, focusing on understanding how aberrant brain stem cell behavior contributes to aging and cancer. He has also received a number of awards, including the Skaggs-Oxford Scholarship (TSRI/Oxford University), Odyssey Fellowship (UT MDACC), President’s Assistant Professorship (NUS), NUS Early Career Research Award and the highly competitive National Research Foundation Fellowship (class of 2017).
彭智培
Pang, Chi Pui
Institute: Faculty of Medicine, The Chinese University of Hong Kong Email address: cppang@cuhk.edu.hk
Prof. Pang is S.H. Ho Professor of Visual Sciences and Professor of Ophthalmology and Visual Sciences, Chinese University of Hong Kong. He is also Director of Shantou University/CUHK Joint Shantou International Eye Center, and former Chairman, Department of Ophthalmology and Visual Sciences, CUHK. His current research includes molecular genomics of age- related eye diseases and children eye diseases, herbal molecules and GHRHR agonists/antagonists. He has received awards from ARVO, APAO, National Science Foundation China, and Chinese Ophthalmological Society. He is convener of the visual sciences program of WOC and APAO Congresses, and reviewer for the Welcome Trust, National Eye Institute (USA), National Medical Research Council (Singapore), National Health & Medical Research Council (Australia), National Science Foundation China, Changjiang Scholar Program China, and other national and international funding organisations. He is also academic reviewer, examiner and honorary/visiting professor of >60 tertiary academic institutions across the world. He has contributed >430 publications in SCI journals, and 21 book chapters, with total citations >15,500 times, H-index 66 and i10-index 273 by Google Scholar.
裴仁军
Pei, Renjun
Institute: Suzhou Institute of Nano-Tech and Nano-Bionics, CAS
Email address: rjpei2011@sinano.ac.cn
Prof. Renjun Pei received his bachelor degree and PhD from Wuhan University, and is currently working as a professor in CAS Key Laboratory of Nano-Bio Interface, Suzhou Institute of Nano-Tech and Nano-Bionics, Chinese Academy of Sciences. He has been the recipient of the CAS Hundred Talents program. He is serving as editorial board member of Scientific Reports. His current research interests include: 1, Biomaterials, injectable hydrogels and 3D bio-printing with stem cells for tissue regeneration. 2, Aptamer SELEX and the applications, including isolation of circulating tumor cells, in vivo MRI and fluorescent probes, targeted delivery platforms. 3, Nano-based disease diagnosis and therapy, for example to cancer. He has published more than 150 papers in peer-reviewed journals, including Nature Nanotechnology, Journal of the American Chemical Society, Angewandte Chemie International Edition, Nucleic Acids Research, Small, Chemistry of Materials.
邵志成
Shao, Zhicheng
Institute: School of Medicine, Xiamen University
Email address: zcshao@xmu.edu.cn
PhD, Principal Investigator, Associate Professor, Xiamen University. Dr. Shao’s research focuses on somatic cell reprogramming, neural regeneration and understanding of schizophrenia pathogenic mechanisms. His research findings have published in Nature Neuroscience, Nature Communications, Cell Reports, Molecular Psychiatry, Neuron, Molecular Therapy, et al.
沈沁
Shen, Qin
Institute: Tongji University
Email address: shenqin@tongji.edu.cn
Dr. Qin Shen obtained Ph.D. degree in Albany Medical College, New York, under the guidance of Dr. Sally Temple, who specializes in neural stem cell development. Her Ph.D. project, completed in 2001, focused on asymmetric cell division in the embryonic murine cerebral cortex. During her Ph.D. and postdoctoral training in Dr. Temple's laboratory, Dr. Shen and colleagues discovered the lineage pattern and timing program of neural stem cells for generating cortical neurons in vitro. Dr. Shen was hired as Assistant Professor in Albany Medical Center and Neural Stem Cell Institute in 2005 and moved to Tsinghua University, Beijing in 2010. Currently, Dr. Shen is a Professor in School of Life Sciences and Technology in Tongji University with a joint appointment at Tongji Hospital, Shanghai. She continues to study the intrinsic and environmental mechanisms regulating neural stem cell self-renewal and cell fate choices. She identified the cellular and molecular structure of the adult SVZ, established endothelial cells as a critical component of the neural stem cell niche and revealed the critical role of VCAM1 in neural stem cell maintenance. Her work has led to more than 30 publications in top journals such as Science, Neuron, Nature Neuroscience, Cell Stem Cells.
王丽强
Wang, Liqiang
Institute: The General Hospital of the People's Liberation Army Email address: liqiangw301@163.com
Dr. Wang earned her Doctorate of Medical Research (biochemistry) from Chinese People’s Liberty Army medical school. She received the nationally recognized Claesa Dohlman Fellowship Award and completed her two-year fellowship in Massachusetts Eye and Eye Hospital affiliated the Harvard Medical School. She worked as visiting scholar in the Department of Biochemistry at Massachusetts Institute of Technology. Her clinical focus is in corneal transplants, keratoprosthesis, refractive surgery, and diseases of the anterior segment of the eye. As a clinical scientist, her research interests include stem cell and regenerative medicine in eye and translation projects such as keratoprosthesis and ocular drug delivery. She is chief scientist of national key R&D Program of China.One of her project “The artificial corneal treatment of end-stage corneal blindness” has won the first prize of the military scientific and technological progress.
王晓昱
Wang, Xiaoyu
Institute: Xiamen International Trust Co., Ltd.
Email address: wdtwang@hotmail.com
Mr. Xiaoyu Wang was first graduated from Guanghua school of Management of Peking University, and then he obtained Master degrees in both investment and MBA from Schulich of York University of Canada. Now he is the General Manager of the equity department of Xiamen International Trust Co., Ltd. He is specialized in PE equity investment. Now he is in charge of operating 300 million capital fund for pharmaceutical and health industry, which is mainly used in bio-pharmaceutical and related fields. He has rich experience in equity investment, and he is an expert in setting up business models and initiating projects.
向孟清
Xiang, Mengqing
Institute: Sun Yat-sen University
Email address: xiangmq3@mail.sysu.edu.cn
Dr. Mengqing Xiang is currently a Professor at the State Key Laboratory of Ophthalmology, Zhongshan Ophthalmic Center, Sun Yat-sen University. He has received a number of honors and awards including the CUSBEA Graduate Study Fellowship, Howard Hughes Medical Institute Postdoctoral Fellowship, Basil O’Connor Starter Scholar Research Award, Sinsheimer Scholar Award, Wolf, Block, Schorr and Solis-Cohen, LLP Award in Auditory Science, Expert in the One-Thousand Talent Program, and Medical Leading Talent in Guangdong Province. His research interests are focused on exploring the molecular mechanism and regulatory gene network of retinal cell specification and differentiation, establishing animal models for retinal degeneration, as well as on inducing retinal/neural cells from somatic/stem cells for retinal repair and regeneration. His group has been leveraging on retinogenic transcription factors to reprogram somatic cells into induced neural stem cells and mature neurons for disease modeling and potential cell replacement therapies of retinal and neurodegenerative diseases.
解亭
Xie, Ting
Institute: Stowers Research Institute
Email address: Tingxie01@yahoo.com
Professor, University of Kansas Medical Center. Currently, He is a full investigator at Stowers Institute for Medical Research and a full professor in University of Kansas Medical Center. He is one of the leaders, Dr. and pioneers in studying the stem cell niche and its mechanisms controlling self-renewal. Dr. Xie was the first to experimentally demonstrate the existence of the stem cell niche. Recently, he has also proposed the differentiation niche for controlling stem cell lineage specification. His laboratory uses Drosophila ovarian germline stem cells as a model system to elucidate the structures and functions of the self-renewal niche and the differentiation niche as well as the molecular and cellular mechanisms underlying self-renewal, differentiation, stem cell competition and aging. Additionally, his lab has demonstrated the roles of various signaling pathways (BMP, Hh, Wnt and Notch), cadherin-mediated cell adhesion, epigenetic factors, non-coding RNAs and various protein complexes (COP9, CCR4-NOT and eIF4) in the regulation of self-renewal and differentiation. Recently, his lab has begun the exploration of stem cell application in treating retinal degenerative diseases and the study on the mechanisms underlying retinal degenerative diseases. Dr. Xie received Hudson Award in 2003.
袭荣文
Xi, Rongwen
Institute: National Institute of Biological Sciences, Beijing
Email address: xirongwen@nibs.ac.cn
Rongwen Xi is an Investigator at the National Institute of Biological Sciences (NIBS), Beijing. Since joining NIBS in 2006, he has been primarily focusing on the molecular regulation of Drosophila midgut stem cells, and has made important contributions on the understanding of the basic principals in niche structure, maintenance signals, and cell fate decisions from intestinal stem cells, and has discovered several novel mechanisms underlying intestinal tumor development. In combination with the mouse models, he is currently investigating whether the transcription factor oscillation model could be a general mechanism governing cell fate decisions from multipotent stem cells, and dissecting out the molecular interactions among intestinal stem cells, differentiated cells and local environment (such as the mesenchymal niche, gut microbiota, etc..) in intestinal homeostasis and metabolic diseases. His long-term goal is to draw an overall picture of the regulatory principles that govern self-renewal and fate decision of intestinal stem cells, and identify novel genes and pathways that could be targeted to treat intestinal diseases.
谢华桃
Xie, Huatao
Institute: Huazhong University of Science and Technology
Email address: huataoxie@hust.edu.cn
Dr. Huatao Xie serves currently as an attending physician in the Department of Ophthalmology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology. Dr. Xie received his Ph.D. degree in 2012 from the Department of Ophthalmology, Union Hospital, Tongji Medical College with a thesis on Niche Regulation of Limbal Stem Cells. Dr. Xie completed his post-doctoral research on Ocular Surface Stem Cells in Schepens Eye Research Institute, Massachusetts Eye and Ear, Harvard Medical School, Boston, MA. His clinical interest focuses on the amniotic membrane transplantation and corneal transplantation for ocular surface and cornea reconstruction. Dr. Xie has published or coauthored 20 journal papers which were cited about 500 times. He also acts as reviewers for ten famous scientific journals.
薛天
Xue, Tian
Institute: University of Science and Technology of China
Email address: xuetian@ustc.edu.cn
Dr. Tian Xue is Professor in School of Life Sciences, University of Science & Technology of China. There are three on-going projects in his labs, including: first, his lab focuses on the mesoscopic structure and function of NIV-associated neuronal circuitry, using techniques such as trans-synaptic viral tracing, electrophysiology, optogenetics, and in vivo deep-brain calcium imaging. His lab also explores the possibilities in vision repair and rescue with a combinatorial approach employing stem cell regeneration, gene editing, and bio-informatics. Another project in his lab is to understand how ipRGCs control the unique kinetics of its light response through photo-transduction mechanisms, and what physiological significance this has for neuronal coding of NIV. He aims to investigate molecular targets that may affect the kinetics of ipRGC-mediated photo-responses, with the aid of transgenic mice, AAV-RNAi, patch-clamp and optogenetic techniques. He will further combine in vivo optogenetics with behavioral tests to reveal the coding pattern of ipRGC-mediated information, and its impact on NIV-associated physiological processes.
徐国彤
Xu, Guotong
Institute: Tongji Medical University
Email address: gtxu@tongji.edu.cn
Prof. Guotong Xu, M.D. (China), Ph.D. in Pharmacy (USA), postdoc in Alcon R&D Center and National Eye Institute. After returning to China, he served as director of Nanjing Ribo Eye Center, chief representative of Orbis Aircraft Eye Hospital in China, deputy director/acting director of Shanghai Health Institute of the Chinese Academy of Sciences, etc. He joined Tongji University in 2008, and served as Executive Vice President and Dean of Medical School. Currently, he is distinguished professor of Tongji University, executive director of Tongji Jiren School of New Student College, director of the Eye Institute, director of the East China Stem Cell Bank, and representative scientific expert of the 10th People's Hospital (ophthalmology) affiliated with Tongji University. His research directions include stem cell resource bank construction and stem cell translational research, therapeutic drug development for diabetic retinopathy, stem cell/gene therapy for retinal degeneration, and mechanisms of cataract/aging and related drug/cell therapy.
徐秀琴
Xu, Xiuqin
Institute: Institute of Stem Cell & Regenerative Medicine, School of Medicine, Xiamen University
Email address: xuxq@xmu.edu.cn
Dr. Xiuqin Xu is a Principal Investigator and Professor at the School of Medicine, Xiamen University. Her research focuses on understanding the mechanisms of pluripotent stem cell (ESC and iPSC) cardiogenesis, with the ultimate goal of developing therapeutic applications for heart disease patients. She was a Senior Scientist at ES Cell International (ESI), a world-renowned regenerative medicine company, where her research led to the successful development of a fully defined and GMP-compliant medium for hESC-derived cardiomyocyte generation. After the acquisition of ESI by a US-based company, she directed the R&D team at the Institute of Medical Biology, A*STAR prior to moving to XMU. Her most recent achievements include the identification of an RNA binding protein Rbm24 as a key splicing regulator that plays an essential role in controlling post-transcriptional networks during ESC transition to cardiac differentiation. This finding offers a global view about how an RNA binding protein influences ESC lineage differentiation through splicing-mediated regulating mechanisms and uncovers potential novel pathways which direct the differentiation of ESCs.
许韧
Xu, Ren
Institute: School of Medicine, Xiamen University
Email address: xurenjp@163.com
Dr. Ren Xu is an independent Principle Investigator (PI) in State Key Laboratory of Cellular Stress Biology, the Professor at School of Medicine in Xiamen University. Dr. Xu earned his Ph.D. in the Department of Orthopedic and Spinal Surgery at Tokyo Medical and Dental University in 2013. He completed postdoctoral training in bone biology at Weill Cornell Medical College, Cornell University co-mentored by Dr. Laurie Glimcher and Matthew Greenblatt. In 2019, Dr. Xu joined School of Medicine at Xiamen University, and run an independent research lab as a PI. His studies focus on skeletal stem cells, bone remodeling and other musculoskeletal diseases, and have been published in top academic journals such as Nature and Nature Medicine. He has won numbers of international academic awards such as John Haddad Young Investigator Award and his research is supported by NSFC. He also served as invited reviewers of more than 10 international journals and a lifetime member of International Chinese Musculoskeletal Research Society.
徐海伟
Xu, Haiwei
Institute: Army Medical University
Email address: haiweixu2001@163.com
Dr. Haiwei Xu is Professor of Physiology and Ophthalmology in Southwest Eye Hospital, Southwest Hospital, Army Medical University, Chongqing, China. Prof Xu is the vice director of Key Lab of Visual Damage and Regeneration & Regeneration of Chongqing. His research interests mainly focus on the mechanisms of stem cell based cell therapy in the neurodegenerative diseases including retinitis pigmentosa and AMD age-related macular degeneration. Except for the traditional cell replacement mechanisms and trophic actions of stem cells, he discovered the active regulatory of the microenvironment by the grafted stem cells. He received grants from the National Key R&D program of China, National Natural Science Foundation and other research funds. Her main findings were published in the journals including Nature Communications, Advanced Science, Molecular Psychiatry, Medicinal Research Review and Cell Discovery.
徐庆国
Xu, Qingguo
Institute: Virginia Commonwealth University, United States
Email address: gxu@vcu.edu
Blick Scholar Assistant Professor of Pharmaceutics, and Ophthalmology at the Virginia Commonwealth University. Dr. Xu received B.E. and M.E. in Polymer Materials and Engineering from Tianjin University, and D.Phil. in Materials Science from University of Oxford at 2009.Dr. Xu was a postdoc fellow in the Wilmer Eye Institute at Johns Hopkins University, where he worked with Justin Hanes PhD and Walter Stark MD, and 3 years later he became a Research Associate Faculty member. Dr. Xu has experience in materials science, drug delivery, nanotechnology, and physiochemical characterization of mucosal and tissue barriers to drug delivery systems. A significant portion of his current work has involved the design and development of new methods for safe, effective drug delivery to the eye to treat various ocular disorders. He is the PI and co-PI of a NIH/NEI R01 grant and a FDA grant. Dr. Xu has authored about 30 research papers and 10 patents and patent applications.
阴正勤
Yin, Zhengqin
Institute: Army Medical University
Email address: qinzyin@aliyun.com
Dr. Zhengqin Yin is currently the Professor and Director of Southwest Eye Hospital, Third Military Medical University（Army Medical University）, Chongqing, China. She was the Vice-President of the 11th Chinese Ophthalmology Society. Chair of Chinese Visual Physiology and Visual Science committee in Chinese Ophthalmology Society. Dr. Zheng Qin Yin is Chief investigator of National Basic Research Program of China (973 Program). She has got 22 national patents and published 307 academic papers including 138 papers in SCI peer-reviewed international journals, chief-edited or edited 11 academic books in Chinese or English. She supervised 36 PhD and 41 masters. Her clinical major are Medical Retina and Pediatric Ophthalmology. Her research focused in basic and clinical research in retinal degeneration diseases and mechanism of plasticity in vision development, as well as clinical basic research of pediatric eye diseases. Her lab got international recognized achievement in neuro-blindness eye diseases, especially in retinal degeneration diseases, in which she led cell therapy study including retinal progenitor cells, bone-marrow stem cells, Olfactory ensheathing cells and etc. The clinical trial of retinal progenitor cells for Retinitis Pigmentosa and hESC-RPE for wet-Age Related Macular Degeneration stands at the leading edge in the world.
袁宝珠
Yuan, Baozhu
Institute: Cell Collection and Research Centre, National Institutes for Food and Drug Control
Email address: fangshi0712@qq.com
Bao-Zhu Yuan, MD & PhD, with an over-30-year experiences in both basic research on cell and molecular biology and translational studies for cancer and stem cells. He serves as a professor in the Cell Collection and Research Center of National Institutes for Food and Drug Control (NIFDC) and a member of the Nation’s Stem Cell Expert Committee for 1) organizing and supervising quality studies and quality validations for various cell therapy products; 2) developing new quality control technologies and standards, including evaluation techniques, reference materials, and evaluation/validation specifications; 3) participating in the regulation of cell therapy products to be used in clinical studies；4) developing new, or revising existing, regulations and technical guidelines, such as the Guidelines for Quality Control and Preclinical Studies of Stem Cells-based Medicinal Products, which was promulgated in August, 2015; 5) acting as the PI for organizing and supervising a research project，i.e. the project of ”Establishing A Standard Evaluation System for Clinical-Grade Stem Cells' Project, which was supported by the Nation’s Key R&D Program-the 2016 ‘Stem Cells and Translational Studies Program”.
张潮
Zhang, Chao
Institute: Weill Cornell Medicine, Cornell University, United States
Email address: chz2009@med.cornell.edu
Instructor, Division of Hematology/Oncology at Weill Cornell Medicine. As an interdisciplinary researcher, he has a solid background in systems biology, statistics, machine learning, big data analysis, and next generation sequencing analysis. In recent years, his research focuses on Precision Medicine on Cancer and Neuron Degenerative Diseases. He built a new computational framework to integrate microbiota abundance, immune signature expression and human genetic variation for clinical cancer research. It not only provides important foundations for understanding the role of the microbiome in cancer development and altering the tumor microenvironment, but also reveals the emerging role of the local microbiome in cancer immunotherapy. In collaboration with Dr. Lorenz Studer (recipient of the MacArthur Fellowship in 2015), he presented the surprising finding that by manipulating the nutrient composition of the culture medium, the pluripotent state of hPSC is dramatically altered.
张宏
Zhang, Hong
Institute: The 2nd Affiliated hospital, Zhejiang University School of Medicine
Email address: hzhang21@zju.edu.cn
Prof. Hong ZHANG is Qiushi Chair Professor of Zhejiang University, the Distinguished Young Scholar of National Natural Science Foundation of China (NSFC) and Principal Investigator of the National Key Research and Development Program of China. He currently serves as Vice President of Shanxi Medical University, Dean of the College of Biomedical Engineering and Instrument Science of Zhejiang University, Director of Institute of Nuclear Medicine and Molecular Imaging of Zhejiang University, Director of Zhejiang Medical PET Center and Chair of Department of Nuclear Medicine at the Second Affiliated Hospital of Zhejiang University School of Medicine. He has been studying and working at Gunma University School of Medicine in Japan, Japanese Society for the Promotion of Science (JSPS), National Institute of Radiological Sciences (NIRS) in Japan and the University of London in UK. Prof. Hong ZHANG is specialized in nuclear medicine and molecular imaging-based major disease theranostics, focuses on functional diagnostic imaging in neurology, oncology, stem cell and gene imaging. He serves as the Editorial Board Members of official journal of Society of Nuclear Medicine and Molecular Imaging (SNMMI, USA), European Association of Nuclear Medicine (EANM), British Society of Nuclear Medicine (BNM) and Japanese Society of Nuclear Medicine (JSNM).
张亮
Zhang, Liang
Institute: School of Life Science, Xiamen University
Email address: zhangxmu@xmu.edu.cn
Dr. Liang Zhang is currently an Associate Professor at School of Life Science, Xiamen University. He obtained his Bachelor degree from Wuhan University in 2003 and PhD degree from Shanghai Institute of Biochemistry and Cell Biology in 2008. He received a postdoctoral training in UT Southwestern Medical Center, and was then appointed as a Principle Investigator in School of Life Science, Xiamen University. His research focus on the mechanisms of genome maintenance and cell fate decision in the Central Nervous System. The relevant findings have been published in journals such as Neuron.
郑俊克
Zheng, Junke
Institute: Shanghai Jiao Tong University School of Medicine
Email address: zhengjunke@shsmu.edu.cn
Ph.D., Principle Investigator, and the winner of National Science Fund for Distinguished Young Scholars. Dr. Zheng got his Ph.D for Developmental Biology at Shanghai Jiao Tong University School of Medicine in 2007. He had the Postdoc (Instructor) training at Alec Zhang’s Lab (2007-2012), Department of Physiology, University of Texas Southwestern Medical Center at Dallas, USA. He was nominated as the Professor in Shanghai Jiao Tong University School of Medicine in 2012. His lab mainly focuses on the studies of metabolic regulations of the stemness of hematopoietic stem cells and leukemia stem cells. He also works on the niche components-immune inhibitory receptor mediated signaling in the activities of hematopoietic stem cells and leukemia stem cells. He has made several important findings related to glucose/amino acid metabolisms and immune inhibitory receptor mediated pathways during hematopoiesis and leukemogenesis, which has been published in Nature, Cell Metabolism, JCI, Blood, Leukemia, Cell Reports and Haematologica et al.
钟秀风
Zhong, Xiufeng
Institute: Sun Yat-sen University
Email address: xzhong13@qq.com
Dr. Xiufeng Zhong is a professor and P.I. at Zhongshan Ophthalmic Center, Sun Yat-Sen University (SYSU), Guangzhou, China. Her clinic service and basic research have been extensively involved in retinal diseases, development and stem cell biology. Her study, for the first time, demonstrate that hiPSCs can generate functional retina with light-sensing photoreceptors in vitro, holding a huge promise for blindness. Her research work has been supported from many funding bodies including NSFC，the National Key R&D Program of China, Science and Tech Project from Guangdong Province. She was the recipient of SYSU “Hundred-Talent Program” award and Guest Lecturer in 2016 Visiting Professor Program of Cole Eye Institute, Cleveland Clinic. Prof. Zhong has served as Reviewer for NSFC and many international journals. She is also a member of Editorial Board of Chinese Journal of Cell and Stem Cell, Guest Editor of Stem Cell Internationals. Currently, her lab aims to explore the mechanisms of retinal development/regeneration and diseases with retinal organoids from hPSCs and develop potential therapeutics.
周庆军
Zhou, Qingjun
Institute: Shandong Eye Institute, Shandong Academy of Medical Sciences
Email address: qjzhou2000@hotmail.com
Dr. Qingjun Zhou is the full professor and executive deputy director of Shandong Provincial Key Laboratory of Ophthalmology in Qingdao, Shandong, China. He is mainly engaged in the basic research of corneal wound healing and tissue-engineered cornea. In corneal wound healing, he conducted the basic research of diabetic corneal complication and found the major mechanism of delayed epithelial wound healing and nerve degeneration. In tissue-engineered cornea, he constructed the tissue-engineered corneal epithelium and promoted the clinical transplantation of cultured allogeneic limbal stem cells in China. For corneal stromal replacement, he developed a novel protective decellularization method for porcine cornea, which achieved the equivalent clinical outcome with human donor cornea during the follow-up of 12 month. For corneal endothelial regeneration, Prof. Zhou is focusing on the inductive differentiation of human embryonic stem cells/induced pluripotent stem cells into functional corneal endothelial cells. Prof. Zhou won above 15 research grants and published over 50 papers in the peer-reviewed journals, including Advanced Functional Materials, Diabetes, Stem cells, Invest Ophthalmol Vis Sci. etc.